Plasma Cell Dyscrasia Clinical Trial
Official title:
Pilot Trial of Homebound Stem Cell Transplantation
In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient's recovery and treatment after ASCT. Studies in other institutions have shown that providing care in the home setting after ASCT is safe, increases patient satisfaction, and can decrease the risk of infection. It is our hope that this new approach of providing care in the home setting will prove to be a feasible and safe option for patients at Memorial Sloan Kettering Cancer Center (MSK).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
| Recruiting |
NCT01186224 -
Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)
|
N/A | |
| Terminated |
NCT00579111 -
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
|
Phase 1/Phase 2 | |
| Completed |
NCT00048412 -
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT04210791 -
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
|
||
| Withdrawn |
NCT05362331 -
Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy
|
N/A | |
| Completed |
NCT02556931 -
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
|
Phase 2 | |
| Completed |
NCT02741999 -
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
|